Liver fibrosis, a condition characterized by the formation of scar tissue in the liver, often results from underlying liver diseases and poses a significant health challenge.
Despite various treatments targeting the root causes of liver diseases, there is currently no medical cure for liver fibrosis. Researchers have been tirelessly exploring new avenues to combat this condition.
Understanding the Cellular Basis of Liver Fibrosis
Liver fibrosis arises from complex cellular processes within the liver.
A Danish/American research team, led by Associate Professor Kim Ravnskjaer, delved into the intricate cellular changes responsible for the formation of scar tissue. The key players in this process are liver stellate cells, named for their star-like appearance.
Discovering the Role of Intestinal Hormones
In a breakthrough study published in the Journal of Hepatology, the research team uncovered previously unknown changes in liver stellate cells that drive fibrosis.
They identified a promising method to deactivate these cells—intestinal hormones, with a focus on vasoactive intestinal polypeptide (VIP). VIP, naturally present in the intestine and neurons, appears to hold the key to keeping stellate cells inactive.
“VIP stimulates the liver’s blood supply but also appears to keep the stellate cells inactive,” explains Kim Ravnskjaer.
Potential for New Treatment Strategies
The findings open doors to potential treatments for liver fibrosis. Researchers envision the development of synthetic hormones designed to target specific receptors on stellate cells.
“This could result in new ways to treat patients. For example, one could develop synthetic hormones designed to target the receptors on specific cells,” says Ravnskjaer.
While research on liver fibrosis treatments is ongoing worldwide, many existing drugs come with significant side effects, limiting their approval. The novel approach of targeting specific cell changes offers the promise of reducing side effects.
“If we target these drugs more towards the cell changes we have discovered, we might be able to avoid many of the side effects,” emphasizes Kim Ravnskjaer.
Translating Findings from Mice to Humans
The initial results were observed in mice subjected to a high-fat, high-sugar diet for a year. Subsequently, the research team confirmed similar cell changes in human liver tissue samples from patients with liver diseases.
This cross-species validation underscores the potential relevance of their discoveries for human patients.
A Long Journey Ahead
While these findings offer hope, the development of new drugs based on this research is still in its early stages and may take years.
However, this work represents a significant step toward unraveling the mysteries of liver fibrosis and brings us closer to effective treatments that could transform the lives of patients with this challenging condition.
If you care about liver health, please read studies about a diet that can treat fatty liver disease and obesity, and coffee drinkers may halve their risk of liver cancer.
For more information about liver health, please see recent studies that anti-inflammatory diet could help prevent fatty liver disease, and results showing vitamin D could help prevent non-alcoholic fatty liver disease.
The research findings can be found in the Journal of Hepatology.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
